Good evening :)
Place Order
Add to Watchlist

Titan Biotech Ltd

TITANBIO Share Price

401.750.14% (-0.55)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹331 cr, stock is ranked 2,099

Stock is 4.20x as volatile as Nifty

TITANBIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹331 cr, stock is ranked 2,099

Stock is 4.20x as volatile as Nifty

TITANBIO Performance & Key Metrics

TITANBIO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
15.432.490.50%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
28.033.541.57%

TITANBIO Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

TITANBIO Company Profile

Titan Biotech Limited makes biological products. The Company offers its products under various categories, such as pharmaceuticals, nutraceuticals, food products, agro nutrients, biotechnology & fermentation, cosmetic ingredients etc.

TITANBIO Similar Stocks (Peers)

Compare with peers Compare with peers 

TITANBIO Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
34.70
34.70
1Y Return
55.74%
55.74%
Buy Reco %
100.00
100.00
PE Ratio
1,523.59
1,523.59
1Y Return
1.12%
1.12%
Buy Reco %
0.00
0.00
PE Ratio
64.97
64.97
1Y Return
18.36%
18.36%
Buy Reco %
70.00
70.00
PE Ratio
48.38
48.38
1Y Return
8.11%
8.11%
Buy Reco %
37.50
37.50
PE Ratio
13.61
13.61
1Y Return
12.33%
12.33%
Buy Reco %
50.00
50.00
Compare with Peers

TITANBIO Forecast

TITANBIO Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

TITANBIO

TITANBIO

Income

Balance Sheet

Cash Flow

TITANBIO Income Statement

TITANBIO Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20.38%, vs industry avg of 10.4%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.05% to 0.08%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 47.84%, vs industry avg of -4.05%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue53.0257.8265.6080.50143.03124.49145.94165.82160.36160.37
Raw Materialssubtract35.8030.5836.5540.2569.9861.6474.6185.33131.02131.03
Power & Fuel Costsubtract2.093.193.253.594.196.678.9810.24
Employee Costsubtract2.896.619.4311.5113.0914.2418.2123.71
Selling & Administrative Expensessubtract3.877.859.408.406.476.319.2110.75
Operating & Other expensessubtract2.722.16-2.632.202.653.433.48-0.25
Depreciation/Amortizationsubtract0.820.931.711.802.222.372.603.334.174.17
Interest & Other Itemssubtract1.482.392.342.351.730.870.751.170.800.81
Taxes & Other Itemssubtract1.171.562.033.3412.377.283.276.682.832.85
EPS2.823.304.408.5436.7026.2430.0530.0826.0626.03
DPS0.750.750.001.001.501.501.802.002.002.00
Payout ratio0.270.230.000.120.040.060.060.070.080.08

TITANBIO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

TITANBIO Stock Peers

TITANBIO Past Performance & Peer Comparison

TITANBIO Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsFertilizers & Agro Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Titan Biotech Ltd15.412.490.50%
Coromandel International Ltd34.707.590.62%
Fertilisers And Chemicals Travancore Ltd1,523.5945.660.02%
UPL Ltd64.971.780.81%

TITANBIO Stock Price Comparison

Compare TITANBIO with any stock or ETF
Compare TITANBIO with any stock or ETF
TITANBIO
Loading...

TITANBIO Holdings

TITANBIO Shareholdings

TITANBIO Promoter Holdings Trend

TITANBIO Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

TITANBIO Institutional Holdings Trend

TITANBIO Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

TITANBIO Shareholding Pattern

TITANBIO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding55.88%0.00%0.01%0.00%44.11%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

TITANBIO Shareholding History

TITANBIO Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

TITANBIO Insider Trades & Bulk Stock Deals

TITANBIO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing TITANBIO stock

smallcases containing TITANBIO stock

Looks like this stock is not in any smallcase yet.

TITANBIO Events

TITANBIO Events

TITANBIO Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

TITANBIO has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.50%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.98 every year

Dividends

Corp. Actions

Announcements

Legal Orders

TITANBIO Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

TITANBIO has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.50%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.98 every year

TITANBIO Upcoming Dividends

TITANBIO Upcoming Dividends

No upcoming dividends are available

TITANBIO Past Dividends

TITANBIO Past Dividends

Cash Dividend

Ex DateEx DateSep 23, 2024

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 23, 2024

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹1.80

Dividend/Share

1.80

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateSep 22, 2022

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 22, 2022

Cash Dividend

Ex DateEx DateSep 16, 2021

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 16, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 17, 2020

TITANBIO Stock News & Opinions

TITANBIO Stock News & Opinions

Earnings
Titan Biotech consolidated net profit declines 19.00% in the March 2025 quarter

Net profit of Titan Biotech declined 19.00% to Rs 4.05 crore in the quarter ended March 2025 as against Rs 5.00 crore during the previous quarter ended March 2024. Sales declined 11.90% to Rs 35.17 crore in the quarter ended March 2025 as against Rs 39.92 crore during the previous quarter ended March 2024. For the full year,net profit declined 13.36% to Rs 21.53 crore in the year ended March 2025 as against Rs 24.85 crore during the previous year ended March 2024. Sales declined 4.64% to Rs 156.45 crore in the year ended March 2025 as against Rs 164.07 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales35.1739.92 -12 156.45164.07 -5 OPM %12.9917.74 -16.2520.89 - PBDT5.877.21 -19 28.5434.86 -18 PBT5.036.37 -21 24.3731.53 -23 NP4.055.00 -19 21.5324.85 -13 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Board of Titan Biotech recommends final dividend

Titan Biotech announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Titan Biotech to conduct board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Titan Biotech consolidated net profit declines 38.77% in the December 2024 quarter

Net profit of Titan Biotech declined 38.77% to Rs 4.39 crore in the quarter ended December 2024 as against Rs 7.17 crore during the previous quarter ended December 2023. Sales declined 16.75% to Rs 38.28 crore in the quarter ended December 2024 as against Rs 45.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales38.2845.98 -17 OPM %12.6723.05 - PBDT6.2910.78 -42 PBT5.109.94 -49 NP4.397.17 -39 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Titan Biotech to hold board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Titan Biotech consolidated net profit rises 2.76% in the September 2024 quarter

Net profit of Titan Biotech rose 2.76% to Rs 6.70 crore in the quarter ended September 2024 as against Rs 6.52 crore during the previous quarter ended September 2023. Sales declined 8.15% to Rs 39.89 crore in the quarter ended September 2024 as against Rs 43.43 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales39.8943.43 -8 OPM %19.4520.08 - PBDT7.818.99 -13 PBT6.728.13 -17 NP6.706.52 3 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Titan Biotech schedules board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Titan Biotech to conduct AGM

Titan Biotech announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Titan Biotech consolidated net profit rises 3.90% in the June 2024 quarter

Net profit of Titan Biotech rose 3.90% to Rs 6.40 crore in the quarter ended June 2024 as against Rs 6.16 crore during the previous quarter ended June 2023. Sales rose 24.06% to Rs 43.11 crore in the quarter ended June 2024 as against Rs 34.75 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales43.1134.75 24 OPM %19.1422.71 - PBDT8.567.88 9 PBT7.527.09 6 NP6.406.16 4 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Titan Biotech to hold board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Titan Biotech Ltd (TITANBIO) today?

    The share price of TITANBIO as on 27th June 2025 is ₹401.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Titan Biotech Ltd (TITANBIO) share?

    The past returns of Titan Biotech Ltd (TITANBIO) share are
    • Past 1 week: 1.08%
    • Past 1 month: -11.97%
    • Past 3 months: -5.52%
    • Past 6 months: -45.02%
    • Past 1 year: -35.07%
    • Past 3 years: 79.19%
    • Past 5 years: 462.28%

  3. What are the peers or stocks similar to Titan Biotech Ltd (TITANBIO)?
  4. What is the dividend yield % of Titan Biotech Ltd (TITANBIO) share?

    The current dividend yield of Titan Biotech Ltd (TITANBIO) is 0.50.

  5. What is the market cap of Titan Biotech Ltd (TITANBIO) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Titan Biotech Ltd (TITANBIO) is ₹331.99 Cr as of 27th June 2025.

  6. What is the 52 week high and low of Titan Biotech Ltd (TITANBIO) share?

    The 52-week high of Titan Biotech Ltd (TITANBIO) is ₹1017.85 and the 52-week low is ₹373.65.

  7. What is the PE and PB ratio of Titan Biotech Ltd (TITANBIO) stock?

    The P/E (price-to-earnings) ratio of Titan Biotech Ltd (TITANBIO) is 15.41. The P/B (price-to-book) ratio is 2.49.

  8. Which sector does Titan Biotech Ltd (TITANBIO) belong to?

    Titan Biotech Ltd (TITANBIO) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.

  9. How to buy Titan Biotech Ltd (TITANBIO) shares?

    You can directly buy Titan Biotech Ltd (TITANBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.